1-7 of 7
Claudia Venturi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis

Fausto Castagnetti, MDPhD, Gabriele Gugliotta, MDPhD, Massimo Breccia, MD, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Francesco Albano, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Luciano Levato, MD, Tamara Intermesoli, MD, Patrizia Pregno, MD, Giuseppe Rossi, MD, Filippo Gherlinzoni, MD, Pietro Leoni, Prof, Francesco Cavazzini, MD, Dario Ferrero, MD, Emilio Usala, MD, Monica Bocchia, MD, Mario Tiribelli, MD, Enrico Montefusco, MD, Simona Sica, Claudia Venturi, PhD, Simona Soverini, Michele Cavo, MD, Giuliana Alimena, MD, Giovanni Martinelli, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Michele Baccarani, MD, Gianantonio Rosti, MD
Journal: Blood
Blood (2015) 126 (23): 2792.
https://doi.org/10.1182/blood.V126.23.2792.2792
Published: 2015
Journal Articles

Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia

Cristina Papayannidis, MD PhD, Anna Candoni, MD, Michele Malagola, Giovanni Marconi, MD, Marco Manfrini, PhD, Giorgia Simonetti, PhD, Elisa Zuffa, PhD, Maria Chiara Abbenante, MD, Sarah Parisi, MD, Stefania Paolini, Chiara Sartor, Eugenia Franchini, Emanuela Ottaviani, Claudia Venturi, PhD, Maria Chiara Fontana, Antonella Padella, Viviana Guadagnuolo, PhD, Maria Teresa Bochicchio, Anna Ferrari, PhD, Simona Soverini, Nicoletta Testoni, Carmen Baldazzi, PhD, Renato Fanin, Domenico Russo, Michele Cavo, MD, Giovanni Martinelli, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2513.
https://doi.org/10.1182/blood.V126.23.2513.2513
Published: 2015
Journal Articles

Clinical Relevance of Low Burden BCR-ABL1 Mutations Detectable By Amplicon Deep Sequencing (DS) in Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients (pts): The Type of Mutation Matters

Simona Soverini, PhD, Caterina De Benedittis, PhD, Claudia Venturi, PhD, Cristina Papayannidis, MD PhD, Manuela Mancini, PhD, Katerina Machova Polakova, Domenico Russo, MD PhD, Paola Bresciani, MD, Alessandra Iurlo, MD PhD, Elisabetta Abruzzese, MD, Federica Sorà, MD PhD, Michele Baccarani, Michele Cavo, MD, Torsten Haferlach, Giovanni Martinelli, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2489.
https://doi.org/10.1182/blood.V126.23.2489.2489
Published: 2015
Journal Articles

Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients

Giovanni Marconi, MD, Cristina Papayannidis, MD PhD, Federico Mosna, Michele Gottardi, Giorgia Simonetti, PhD, Simona Soverini, Antonio Curti, MD PhD, Elisa Zuffa, PhD, Maria Chiara Abbenante, MD, Sarah Parisi, MD, Stefania Paolini, MD, Chiara Sartor, Eugenia Franchini, Emanuela Ottaviani, Claudia Venturi, PhD, Maria Chiara Fontana, Antonella Padella, Viviana Guadagnuolo, PhD, Maria Teresa Bochicchio, Anna Ferrari, PhD, Nicoletta Testoni, Carmen Baldazzi, PhD, Marco Manfrini, PhD, Debora Capelli, MD, Piero Galieni, Andrea Piccin, MD, Giuseppe Visani, MD, Francesco Rodeghiero, Cristina Tecchio, Filippo Gherlinzoni, MD, Michele Cavo, Giovanni Martinelli, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3198.
https://doi.org/10.1182/blood.V126.23.3198.3198
Published: 2015
Journal Articles

Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing

Simona Soverini, PhD, Caterina De Benedittis, Cristina Papayannidis, MD, Luca Zazzeroni, Claudia Venturi, PhD, Ilaria Iacobucci, PhD, Domenico Russo, MD PhD, Paola Bresciani, Mario Luppi, Michele Baccarani, MD, Michele Cavo, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2014) 124 (21): 2259.
https://doi.org/10.1182/blood.V124.21.2259.2259
Published: 2014
Journal Articles

Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

Gabriele Gugliotta, MD, Fausto Castagnetti, MD, Massimo Breccia, MD, Luciano Levato, MD, Giovanna Rege-Cambrin, MD, Luigiana Luciano, MD, Monica Bocchia, MD, Antonella Russo Rossi, MD, Emilio Usala, MD, Marzia Salvucci, MD, Antonella Gozzini, MD, Gianni Binotto, MD, Michele Cedrone, MD, Elisabetta Abruzzese, MD, Paolo Avanzini, MD, Claudia Venturi, PhD, Nicoletta Testoni, PhD, Simona Soverini, PhD, Giuliana Alimena, MD, Michele Cavo, MD, Giovanni Martinelli, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Michele Baccarani, MD, Gianantonio Rosti
Journal: Blood
Blood (2014) 124 (21): 3141.
https://doi.org/10.1182/blood.V124.21.3141.3141
Published: 2014
Journal Articles

Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome

Cristina Papayannidis, MD PhD, Anna Ferrari, PhD, Stefania Paolini, Carmen Baldazzi, PhD, Chiara Sartor, Abbenante maria Chiara, Giovanni Marconi, Sarah Parisi, Francesca Volpato, Ilaria Iacobucci, PhD, Antonella Padella, Viviana Guadagnuolo, PhD, Margherita Perricone, Valentina Robustelli, Claudia Venturi, PhD, Giorgia Simonetti, PhD, Alberto Conficoni, Katia Mancuso, MD, Beatrice Zannetti, Emanuela Ottaviani, Elisa Zuffa, PhD, Eugenia Franchini, Nicoletta Testoni, BSc, Michele Cavo, MD, Giovanni Martinelli
Journal: Blood
Blood (2014) 124 (21): 484.
https://doi.org/10.1182/blood.V124.21.484.484
Published: 2014